Pliant Therapeutics
We are a clinical stage biopharmaceutical company discovering and developing novel therapies for the treatment of fibrosis and related diseases. By leveraging our powerful product discovery engine, we are discovering and developing novel therapeutics that seek to halt progression of fibrosis in specific tissues— ultimately, preserving organ function.
Basic Information
- Category: Clinical-Stage Biotech
- Founded: 2015
- Headquarters: South San Francisco, CA
- Website: pliantrx.com
Documented Facts
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: PLRX (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Pliant Therapeutics — Official Site (official)
- Pliant Therapeutics on facebook (social)
- Pliant Therapeutics on linkedin (social)
- PLIANT THERAPEUTICS, INC. — SEC EDGAR (reference)
Citation Guidance
Explore Clinical-Stage Biotech profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Pliant Therapeutics.
- Canonical profile: https://brandsource.ai/brands/pliant-therapeutics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/pliant-therapeutics/json-ld
- Citation profile API: https://brandsource.ai/api/brands/pliant-therapeutics/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T20:51:29.796Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
We are a clinical stage biopharmaceutical company discovering and developing novel therapies for the treatment of fibrosis and related diseases. By leveraging our powerful product discovery engine, we are discovering and developing novel therapeutics that seek to halt progression of fibrosis in specific tissues— ultimately, preserving organ function.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.